BioMarker Strategies Competitors and Similar CompaniesClear all
BioMarker Strategies's competitors and similar companies include Synairgen, Quark Pharmaceuticals, NantHealth and Virtus Health.
 BioMarker Strategies BioMarker Strategies offers SnapPath, a live tumor cell testing platform that improves the treatment of cancer. |  Synairgen Synairgen is a respiratory drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic. |  Quark Pharmaceuticals Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics. |  NantHealth NantHealth is a healthcare company providing an evidence-based platform for healthcare diagnostics. | ||
Founding Date | Founding Date 2007 | Founding Date N/A | Founding Date 1994 | Founding Date 2007 | Founding Date 2008 |
Type | Type Private | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Derwood, US HQ | Locations Southampton, GB HQ | Locations Newark, US HQ | Locations El Segundo, US HQ | Locations Greenwich, AU HQ Clonskeagh, IE Singapore, SG |
Employees | Employees 3 | Employees 36 | Employees 781% decrease | Employees 36512% increase | Employees 1,300 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 12.4 m | Valuation ($) N/A | Valuation ($) 10.4 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $67m (FY, 2022) | Revenue (est.) $322.9m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $28.8m (FY, 2022) | Cost of goods $87.4m (FY, 2021) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $38.2m (FY, 2022) | Gross profit $246.4m (FY, 2021) |
Net income | Net income N/A | Net income (£6.8m) (FY, 2024) | Net income N/A | Net income ($67.8m) (FY, 2022) | Net income $43.8m (FY, 2021) |
Funding | |||||
Latest funding round | Latest funding round $ 525k (over 9 years ago) | Latest funding round N/A | Latest funding round $ 10m (almost 16 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 5.7m | Total funding raised N/A | Total funding raised $ 37m | Total funding raised $ 547.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Synairgen
HQ
Southampton, GB
Employees
36
Synairgen is a respiratory drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic.
View companyQuark Pharmaceuticals
HQ
Newark, US
Employees
78↓ 1% decrease
Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics.
View companyNantHealth
HQ
El Segundo, US
Employees
365↑ 12% increase
NantHealth is a healthcare company providing an evidence-based platform for healthcare diagnostics.
View company
Virtus Health
HQ
Greenwich, AU
Employees
1,300
Virtus Health is a health care service provider.
View company